On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Egon Pfarr

ResearcherPublications, citations & collaboration network

Egon Pfarr is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Egon Pfarr have?

ScholarIQindexed works

Egon Pfarr has 10 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Egon Pfarr have?

ScholarIQcitation count

Egon Pfarr has 95 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Egon Pfarr?

ScholarIQh-index

Egon Pfarr has an h-index of 3 in OpenAlex.

What is the i10-index of Egon Pfarr?

ScholarIQi10-index

Egon Pfarr has an i10-index of 2 in OpenAlex.

What is the OpenAlex record for Egon Pfarr?

ScholarIQopenalex

The OpenAlex for Egon Pfarr is on the source record.

What are the most-cited papers on Egon Pfarr?

ScholarIQmost cited works
Therapeutic Use of the Natriuretic Peptide Ularitide in Acute Renal Failure
Markus Meyer, Egon Pfarr, G. Schirmer, H. J. Überbacher, Klaus Schöpe, Erwin Böhm, Thomas Flüge, P Mentz, P. Scigalla, Wolf‐Georg Forssmann
Renal Failure. 199964 CitationsOPEN ACCESS
Effect of reteplase on hemostasis variables: analysis of fibrin specifity, relation to bleeding complications and coronary patency
Rainer Meierhenrich, J. Carlsson, E. Seifried, Egon Pfarr, A. Smolarz, Karl-Ludwig Neuhaus, Ulrich Tebbe
International Journal of Cardiology. 199823 Citations
EMPAGLIFLOZIN REDUCES MORTALITY AND HOSPITALIZATION FOR HEART FAILURE IN PATIENTS WITH OR WITHOUT A HISTORY OF MYOCARDIAL INFARCTION OR STROKE AT BASELINE
David Fitchett, Silvio E. Inzucchi, Steven Sambevski, Stefan Kaspers, Egon Pfarr, Jyothis T. George, Bernard Zinman
Journal of the American College of Cardiology. 20183 Citations
Thrombolytic therapy in acute massive pulmonary embolism Double bolus reteplase versus conventional alteplase infusion in a randomized controlled trial
U Tebbe, Andreas Graf, W. Kamke, Klaus Bonaventura, R. Zahn, Florian Forycki, Gerhard Kratzsch, Egon Pfarr, Erich Boehm, A. Smolarz
19972 Citations
Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY Trial
Anastasia Uster, Nihar R. Desai, Sankar D. Navaneethan, Egon Pfarr, Anna Mazo
Clinical Therapeutics. 20252 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial